We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

45 hedge funds and large institutions have $8.62M invested in Pear Therapeutics, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 3 increasing their positions, reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

785% more capital invested

Capital invested by funds: $974K → $8.62M (+$7.64M)

375% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 8

200% more funds holding

Funds holding: 15 → 45 (+30)

Holders
45
Holders Change
+30
Holders Change %
+200%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
3
Reduced
–
Closed
8
Calls
$2.76M
Puts
–
Net Calls
+$2.76M
Net Calls Change
+$2.74M

Top Buyers

Rank Fund Capital Flow
1
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$427K
2
AC
Aristeia Capital
Connecticut
+$349K
3
KCM
Kingstown Capital Management
New York
+$327K
4
KC
Kepos Capital
New York
+$218K
5
GCL
Glazer Capital LLC
New York
+$217K

Top Sellers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
-$201K
2
BFM
Boothbay Fund Management
New York
-$150K
3
OCM
Oribel Capital Management
New York
-$67K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$48K
5
FTCM
Fir Tree Capital Management
New York
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.81M +$160K +183,465 New
PSAMP
2
P. Schoenfeld Asset Management (PSAM)
New York
$725K +$427K +489,771 New
AC
3
Aristeia Capital
Connecticut
$592K +$349K +400,000 New
KCM
4
Kingstown Capital Management
New York
$555K +$327K +375,000 New
SC
5
Sculptor Capital
New York
$402K +$186K +213,302 +320%
KC
6
Kepos Capital
New York
$370K +$218K +250,000 New
GCL
7
Glazer Capital LLC
New York
$367K +$217K +248,096 New
Citadel Advisors
8
Citadel Advisors
Florida
$334K +$10 +11 +0%
AGC
9
Angelo Gordon & Co
New York
$329K +$29.1K +33,332 New
PC
10
Periscope Capital
Ontario, Canada
$304K +$180K +206,000 New
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
$280K +$175K +200,000 New
LA
12
Linden Advisors
New York
$237K +$144K +165,114 New
MCM
13
Moore Capital Management
New York
$233K +$145K +166,666 New
AGM
14
Alpine Global Management
New York
$222K +$131K +150,000 New
CCA
15
Castle Creek Arbitrage
Colorado
$167K +$102K +116,666 New
Verition Fund Management
16
Verition Fund Management
Connecticut
$162K +$48.3K +55,385 +92%
CL
17
CSS LLC
Illinois
$154K +$90.6K +103,830 New
TCA
18
Taconic Capital Advisors
New York
$140K +$87.3K +100,000 New
UOC
19
UBS O'Connor
Illinois
$120K – – –
DKCM
20
Davidson Kempner Capital Management
New York
$117K +$72.7K +83,332 New
TI
21
Telemetry Investments
New York
$103K +$64K +73,371 New
BI
22
Bulldog Investors
New Jersey
$102K +$60.1K +68,910 New
PI
23
PEAK6 Investments
Illinois
$99K +$58.2K +66,666 New
Hudson Bay Capital Management
24
Hudson Bay Capital Management
Connecticut
$77K +$47.9K +54,836 New
LP
25
LMR Partners
United Kingdom
$74K +$43.6K +50,000 New
1
2 3

PEARW Hedge Fund Activity: Q2 2021 in Review

45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q2 2021, worth a combined $8.62M — up 785% from $974K a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new PEARW positions and 8 closed out — a net gain of 30 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was P. Schoenfeld Asset Management (PSAM), opening a new position worth an estimated $427K. The largest seller was Saba Capital Management, exiting entirely with an estimated $201K sold.

  • 45 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q2 2021, up from 15 in Q1 2021.
  • Funds reported $8.62M of Pear Therapeutics, Inc. Warrant stock for Q2 2021, up 785% quarter-over-quarter.
  • 38 funds opened new Pear Therapeutics, Inc. Warrant positions in Q2 2021 and 8 closed out, a net change of +30 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q2 2021 was P. Schoenfeld Asset Management (PSAM), an estimated $427K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q2 2021 was Saba Capital Management, an estimated $201K sold.

Based on aggregated 13F filings for Q2 2021.